Ma’s team (Ma et al., 2019)further demonstrated that DHM inhibits HSC activation by modulating the SIRT1/TGF-β1/Smad3 signaling and autophagy pathways, effectively attenuating CCL4-induced hepatic fibrosis. The gene discussed is TGFB1; the disease is Hepatic fibrosis.